Please enable Javascript
NCCN 2023 Annual Conference
Real-World Duration of Venetoclax Treatment Varied From Approved Dosing Schedule
Dustin Samples
Conferences
|
October 17, 2023
The approved dosing schedule for venetoclax is time-limited, but how many patients follow the schedule?
Read More
Origins and Underlying Mechanism of Sequential or Concurrent CLL/CML
Dustin Samples
Conferences
|
October 17, 2023
Though rare, CLL and CML sometimes occur sequentially or concurrently. But what is the mechanism behind the relationship?
Read More
Trial for Non-Melanoma Skin Cancer in Patients With CLL Now Enrolling
Dustin Samples
Conferences
|
October 17, 2023
In a currently enrolling trial, patients with CLL and NMSC will receive experimental treatment with nicotinamide.
Read More
Updated Treatment Guidelines for CLL/SLL
Dustin Samples
Conferences
|
October 17, 2023
Deborah Stephens, DO, presented the recommendations and algorithms for first-, second-, and third-line CLL/SLL therapy.
Read More
Advertisement
Advertisement